The import ban on the Chikalthana facility excludes five products, but includes Toprol
generic, the company added.
Reddy's launched its generic version of Toprol
XL tablets in the range of 25 mg, 50 mg, 100 mg and 200 mg.
In February of this year, AstraZeneca filed suit against Andrx for patent infringement for the 50 mg dose form of TOPROL
Global generics revenue climbed 42% in the quarter to $571 million, with a boost from new international markets, the launch of new dosage strengths of Watson's generic version of AstraZeneca Plc's (London GBR) Toprol
ER and higher sales of oral contraceptives.
The plaintiffs allege among other things that AstraZeneca engaged in monopoly practices that forced them to pay higher prices for Toprol
She was, however, on 13 outpatient medications: Lantus, Singulair, aspirin, Niferex, Toprol
, Lasix, Zestril, Lipitor, propoxyphene, Aldactone, Plavix, Prilosec, and Cardizem, as well as home oxygen.
I take daily doses of baby aspirin, Lipitor, and Toprol
Pharmaceuticals giant Astra- Zeneca will announce its calendar 2005 results tomorrow and will need to serve up something special to restore confidence after recently losing a big US court case regarding the patent on its blockbuster drug Toprol
Clinical data and interviewed thought leaders also indicate that the regimen of aspirin (Bayer's Aspirin, generics) plus ticagrelor (AstraZeneca's Brilinta/Brilique) plus atorvastatin (Pfizer's Lipitor, generics) plus metoprolol (AstraZeneca's Toprol
, Novartis's Lopressor, generics) plus ramipril (Pfizer's Altace, Sanofi's Triatec, AstraZeneca's Vesdil, generics) has advantages on the attribute of reduced incidence of mortality over the sales-leading regimen for post-myocardial infarction--aspirin plus clopidogrel (Bristol-Myers Squibb/Sanofi's Plavix/Iscover, generics) plus atorvastatin plus metoprolol plus ramipril.
AstraZeneca Plc said first-quarter earnings per share beat analysts' estimates after Novartis AG stopped shipping of generic copies of heart medicine Toprol
Investors, however, remained concerned about a challenge to heart drug Toprol
The court found that patents on Toprol
XL - which were due to expire in September 2007 - were "unenforceable" in a case against rival drugmakers.
Drugs giant AstraZeneca slumped 58p to 2507p as a report showed its heart failure treatment Toprol
is not as good as a planned rival from Glaxo and Roche.
Generic competition to heart drug Toprol
XL in the U.
Another notable faller was AstraZeneca which tumbled 121p to 2680p after it lost a key patent case in the US over its top heart drug Toprol